Immucell Corp
In Vitro & In Vivo Diagnostic Substances · Portland, ME, United States
- PrincipalsBoekhorst Paul Francis Olivier tePresident and CEOTimothy C FioriChief Financial Officerand 3 more
- CompanyImmucell CorpPortland, ME, United States
- Phone line+1 (207) 878-2770General business
Immucell Corp /De/ is an SEC-registered Nasdaq-listed company (ticker ICCC) classified under SIC 2835: In Vitro & In Vivo Diagnostic Substances.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2835 — In Vitro & In Vivo Diagnostic Substances — SEC EDGAR company submissions
People 5
Chief executive
Boekhorst Paul Francis Olivier tePresident and CEO
Finance
Timothy C FioriChief Financial Officer
Sales & commercial
Bobbi Jo BrockmannVP of Sales and Marketing
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Timothy C Fiori — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Bobbi Jo Brockmann — VP of Sales and Marketing
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗David Scott Tomsche — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Boekhorst Paul Francis Olivier te — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
InMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityIceCure Medical Ltd.Biotechnology · Caesarea1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capability